Evaluation of adapted dermocosmetic regimens for perimenopausal and menopausal women using an artificial intelligence-based algorithm and quality of life questionnaires: An open observational study.
artificial intelligence
dermocosmetic
menopause
quality of life
skin aging
Journal
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
ISSN: 1600-0846
Titre abrégé: Skin Res Technol
Pays: England
ID NLM: 9504453
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
26
01
2023
accepted:
04
05
2023
medline:
1
8
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
ppublish
Résumé
The decline in estrogen levels from several years before (perimenopause) and during menopause has various negative effects, including skin specific issues, which often receive less attention than other menopausal symptoms despite having a significant negative effect on quality of life (QoL). The objective of this study was to evaluate the effectiveness of anti-aging dermocosmetic products designed for women during the perimenopause and menopause. An open study of 101 perimenopausal women (no menstruation for 4-12 months or irregular menstruation for <5 years) and 101 menopausal women (no menstruation for >12 months), not taking hormone replacement therapy, was conducted. Adapted dermocosmetic regimens, specific to each group (day cream, night cream and serum), were applied for 56 days. Assessments included automatic artificial intelligence diagnostics of eight clinical facial signs, hydration and transepidermal water loss (TEWL), and a menopause skin QoL questionnaire. Mean age was 50 ± 3.9 years (range 41-57) and 59 ± 3.8 years (range 50-66) for the perimenopause and menopause groups, respectively. Significant improvements in wrinkles and vascular signs, increases in hydration, decreases in TEWL, and a positive impact on QoL were observed after 56 days of application of the respective dermocosmetic regimens for both the perimenopause and menopause groups. The anti-aging skin care products designed specifically for perimenopausal and menopausal women increased skin hydration and improved wrinkles with a positive impact on QoL.
Sections du résumé
BACKGROUND
BACKGROUND
The decline in estrogen levels from several years before (perimenopause) and during menopause has various negative effects, including skin specific issues, which often receive less attention than other menopausal symptoms despite having a significant negative effect on quality of life (QoL). The objective of this study was to evaluate the effectiveness of anti-aging dermocosmetic products designed for women during the perimenopause and menopause.
MATERIALS AND METHODS
METHODS
An open study of 101 perimenopausal women (no menstruation for 4-12 months or irregular menstruation for <5 years) and 101 menopausal women (no menstruation for >12 months), not taking hormone replacement therapy, was conducted. Adapted dermocosmetic regimens, specific to each group (day cream, night cream and serum), were applied for 56 days. Assessments included automatic artificial intelligence diagnostics of eight clinical facial signs, hydration and transepidermal water loss (TEWL), and a menopause skin QoL questionnaire.
RESULTS
RESULTS
Mean age was 50 ± 3.9 years (range 41-57) and 59 ± 3.8 years (range 50-66) for the perimenopause and menopause groups, respectively. Significant improvements in wrinkles and vascular signs, increases in hydration, decreases in TEWL, and a positive impact on QoL were observed after 56 days of application of the respective dermocosmetic regimens for both the perimenopause and menopause groups.
CONCLUSION
CONCLUSIONS
The anti-aging skin care products designed specifically for perimenopausal and menopausal women increased skin hydration and improved wrinkles with a positive impact on QoL.
Identifiants
pubmed: 37522490
doi: 10.1111/srt.13349
pmc: PMC10293886
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13349Informations de copyright
© 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd.
Références
Int J Cosmet Sci. 2019 Feb;41(1):67-78
pubmed: 30664236
Am J Clin Dermatol. 2003;4(6):371-8
pubmed: 12762829
Eur J Dermatol. 2008 Jan-Feb;18(1):36-40
pubmed: 18086587
Obstet Gynecol. 1987 Dec;70(6):840-5
pubmed: 3120067
J Eur Acad Dermatol Venereol. 2020 Jul;34 Suppl 4:4-25
pubmed: 32677068
J Cosmet Dermatol. 2018 Jun;17(3):282-288
pubmed: 29436770
Acta Derm Venereol. 2017 Apr 6;97(4):541-542
pubmed: 27840889
Clin Cosmet Investig Dermatol. 2021 Sep 14;14:1227-1246
pubmed: 34548803
Maturitas. 1994 Oct;19(3):211-23
pubmed: 7799828
Dermatol Ther. 2007 Sep-Oct;20(5):314-21
pubmed: 18045356
J Drugs Dermatol. 2017 Sep 1;16(9):884-890
pubmed: 28915283
World Health Organ Tech Rep Ser. 1996;866:1-107
pubmed: 8942292
J Am Acad Dermatol. 2005 Oct;53(4):555-68; quiz 569-72
pubmed: 16198774
Br J Dermatol. 2000 Sep;143(3):524-31
pubmed: 10971324
Dermatoendocrinol. 2012 Jul 1;4(3):253-8
pubmed: 23467280
J Clin Aesthet Dermatol. 2017 Jul;10(7):14-17
pubmed: 29104718
Clin Dermatol. 2009 Sep-Oct;27(5):495-501
pubmed: 19695482
Br J Dermatol. 2005 Sep;153(3):626-34
pubmed: 16120154
J Dermatol. 2008 Oct;35(10):637-42
pubmed: 19017042
Clin Cosmet Investig Dermatol. 2020 Oct 05;13:751-758
pubmed: 33116738
Am J Obstet Gynecol. 1994 Feb;170(2):642-9
pubmed: 8116726
J Invest Dermatol. 2019 Aug;139(8):1638-1647.e3
pubmed: 30776433
Int J Cosmet Sci. 2019 Oct;41(5):437-442
pubmed: 31310331
J Cosmet Dermatol. 2013 Dec;12(4):267-74
pubmed: 24305425
Arch Dermatol. 2008 Sep;144(9):1129-40
pubmed: 18794456
BMC Complement Altern Med. 2016 Nov 11;16(1):460
pubmed: 27835979
Clin Exp Dermatol. 2001 Oct;26(7):600-7
pubmed: 11696064
Horm Metab Res. 2007 Feb;39(2):85-95
pubmed: 17326004
Int J Gynaecol Obstet. 2000 Jan;68(1):35-41
pubmed: 10687834
Climacteric. 2022 Oct;25(5):434-442
pubmed: 35377827
Skin Res Technol. 2021 Sep;27(5):880-890
pubmed: 33822402
Skin Res Technol. 2019 Jan;25(1):25-29
pubmed: 29863296
J Eur Acad Dermatol Venereol. 2022 Jan;36 Suppl 2:5-15
pubmed: 34979589
Int J Cosmet Sci. 2019 Oct;41(5):472-478
pubmed: 31339574
Dermatol Ther. 2022 Dec;35(12):e15903
pubmed: 36200921
Skin Res Technol. 2019 Sep;25(5):612-617
pubmed: 30942506
Dermatology. 2002;204(1):17-22
pubmed: 11834844
Dermatol Ther (Heidelb). 2021 Feb;11(1):53-69
pubmed: 33242128
J Cosmet Dermatol. 2007 Mar;6(1):59-65
pubmed: 17348998
Clin Interv Aging. 2007;2(3):283-97
pubmed: 18044179
Eur J Dermatol. 2011 Mar-Apr;21(2):191-6
pubmed: 21454149
BMC Complement Altern Med. 2016 Dec 3;16(1):497
pubmed: 27912751
J Cosmet Dermatol. 2004 Apr;3(2):88-93
pubmed: 17147561